Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $4.4 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.